About
The Industry’s Leading Forum Focused on Securing & Scaling
Radiopharmaceutical Manufacturing & Supply
With radiopharmaceutical pipelines expanding, clinical programs progressing, and investments surging across the field, the pressure is mounting to ensure timely, compliant, and high-quality drug production. As demand grows and isotope access remains constrained, the need for coordinated, forward-thinking manufacturing and supply chain strategies is more critical than ever.
The 3rd TRP Supply Chain & Manufacturing Summit returns as the go-to platform for industry leaders tackling isotope bottlenecks, refining GMP production, and futureproofing distribution networks to sustain clinical and commercial momentum.
Tailored for professionals advancing CMC, regulatory, QC, sourcing and supply chain functions, this year’s summit welcomes expert insight from AstraZeneca, Novartis, Clarity Pharmaceuticals, Ratio Therapeutics, ImaginAB, and more – all driving innovation at the forefront of radiopharmaceutical delivery.
What You Can Expect in 2025:
Uncover emerging solutions to radioisotope supply challenge by addressing logistics bottlenecks, comparing centralized versus local production models, managing the impact of transport delays on dose integrity, and optimizing tracking and planning for clinical demand.
Advance your radiopharmaceutical manufacturing strategy by exploring scalable production strategies, efficient Phase 3 to commercial transitions, and flexible designs that accommodate isotope variability and short half-lives.
Gain regulatory clarity to accelerate your clinical trials with practical guidance on agency-specific DMF expectations, equipment standards, and balancing transparency with IP protection – designed to strengthen alignment between pharma and supplier partnerships.
Ensure consistent quality across radiopharmaceutical operations by managing supplier and CDMO oversight, implementing strong quality management systems throughout clinical and commercial stages, and leveraging quality metrics to guide risk management and decision-making.
Strengthen your scientific and commercial partnerships by connecting with the leaders driving the field forward – understand what’s needed in 2025 to build effective collaborations that support clinical and commercial success.
Join this conference to uncover how manufacturing and supply chain innovations can sustain momentum and deliver on the promise of targeted radiopharmaceuticals.
Audience Breakdown:
